Guidance regarding COVID-19 for survivors of childhood,
adolescent, and young adult cancer: A statement from the
International Late Effects of Childhood Cancer Guideline
Harmonization Group

J 2020

Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group

VERBRUGGEN, L. C.; Y. H. WANG; S. H. ARMENIAN; M. J. EHRHARDT; H. J. H. VAN DER PAL et al.

Základní údaje

Originální název

Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group

Autoři

Vydání

PEDIATRIC BLOOD & CANCER, HOBOKEN, WILEY, 2020, 1545-5009

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30209 Paediatrics

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 3.167

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/20:00116603

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

childhood adolescent and young adult (CAYA) cancer survivors; COVID-19; late effects of cancer treatment

Štítky

14110321, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 5. 1. 2021 13:30, Mgr. Tereza Miškechová

Anotace

V originále

Childhood, adolescent, and young adult (CAYA) cancer survivors may be at risk for a severe course of COVID-19. Little is known about the clinical course of COVID-19 in CAYA cancer survivors, or if additional preventive measures are warranted. We established a working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) to summarize existing evidence and worldwide recommendations regarding evidence about factors/conditions associated with risk for a severe course of COVID-19 in CAYA cancer survivors, and to develop a consensus statement to provide guidance for healthcare practitioners and CAYA cancer survivors regarding COVID-19.

Citovat

VERBRUGGEN, L. C.; Y. H. WANG; S. H. ARMENIAN; M. J. EHRHARDT; H. J. H. VAN DER PAL; E. C. VAN DALEN; J. W. VAN AS; E . BARDI; K. BAUST; C. BERGER; E. CASTAGNOLA; K. A. DEVINE; J . GEBAUER; J. G. MARCHAK; A. W. GLASER; A. H. GROLL; G. M. HAEUSLER; J. DEN HARTOGH; R. HAUPT; L. HJORTH; M. KATO; Tomáš KEPÁK; M. M. W. KOOPMAN; T. LANGER; M. MAEDA; G. MICHEL; M. MURACA; P. C. NATHAN; S. R. VAN DEN OEVER; V. PAVASOVIC; S. SATO; F. SCHULTE; L. L. SUNG; W. TISSING; A. UYTTEBROECK; R. L. MULDER; C. KUEHNI; R. SKINNER; M. M. HUDSON a L. C. M. KREMER. Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group. PEDIATRIC BLOOD & CANCER. HOBOKEN: WILEY, 2020, roč. 67, č. 12, s. 1-10. ISSN 1545-5009. Dostupné z: https://doi.org/10.1002/pbc.28702.

@article{1683698,
   author = {Verbruggen, L. C. and Wang, Y. H. and Armenian, S. H. and Ehrhardt, M. J. and van der Pal, H. J. H. and van Dalen, E. C. and van As, J. W. and Bardi, E . and Baust, K. and Berger, C. and Castagnola, E. and Devine, K. A. and Gebauer, J . and Marchak, J. G. and Glaser, A. W. and Groll, A. H. and Haeusler, G. M. and den Hartogh, J. and Haupt, R. and Hjorth, L. and Kato, M. and Kepák, Tomáš and Koopman, M. M. W. and Langer, T. and Maeda, M. and Michel, G. and Muraca, M. and Nathan, P. C. and van den Oever, S. R. and Pavasovic, V. and Sato, S. and Schulte, F. and Sung, L. L. and Tissing, W. and Uyttebroeck, A. and Mulder, R. L. and Kuehni, C. and Skinner, R. and Hudson, M. M. and Kremer, L. C. M.},
   article_location = {HOBOKEN},
   article_number = {12},
   doi = {https://doi.org/10.1002/pbc.28702},
   keywords = {childhood adolescent and young adult (CAYA) cancer survivors; COVID-19; late effects of cancer treatment},
   language = {eng},
   issn = {1545-5009},
   journal = {PEDIATRIC BLOOD & CANCER},
   title = {Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group},
   url = {https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pbc.28702},
   volume = {67},
   year = {2020}
}

TY  - JOUR
ID  - 1683698
AU  - Verbruggen, L. C. - Wang, Y. H. - Armenian, S. H. - Ehrhardt, M. J. - van der Pal, H. J. H. - van Dalen, E. C. - van As, J. W. - Bardi, E . - Baust, K. - Berger, C. - Castagnola, E. - Devine, K. A. - Gebauer, J . - Marchak, J. G. - Glaser, A. W. - Groll, A. H. - Haeusler, G. M. - den Hartogh, J. - Haupt, R. - Hjorth, L. - Kato, M. - Kepák, Tomáš - Koopman, M. M. W. - Langer, T. - Maeda, M. - Michel, G. - Muraca, M. - Nathan, P. C. - van den Oever, S. R. - Pavasovic, V. - Sato, S. - Schulte, F. - Sung, L. L. - Tissing, W. - Uyttebroeck, A. - Mulder, R. L. - Kuehni, C. - Skinner, R. - Hudson, M. M. - Kremer, L. C. M.
PY  - 2020
TI  - Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group
JF  - PEDIATRIC BLOOD & CANCER
VL  - 67
IS  - 12
SP  - 1-10
EP  - 1-10
PB  - WILEY
SN  - 15455009
KW  - childhood adolescent and young adult (CAYA) cancer survivors
KW  - COVID-19
KW  - late effects of cancer treatment
UR  - https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pbc.28702
L2  - https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pbc.28702
N2  - Childhood, adolescent, and young adult (CAYA) cancer survivors may be at risk for a severe course of COVID-19. Little is known about the clinical course of COVID-19 in CAYA cancer survivors, or if additional preventive measures are warranted. We established a working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) to summarize existing evidence and worldwide recommendations regarding evidence about factors/conditions associated with risk for a severe course of COVID-19 in CAYA cancer survivors, and to develop a consensus statement to provide guidance for healthcare practitioners and CAYA cancer survivors regarding COVID-19.
ER  -

VERBRUGGEN, L. C.; Y. H. WANG; S. H. ARMENIAN; M. J. EHRHARDT; H. J. H. VAN DER PAL; E. C. VAN DALEN; J. W. VAN AS; E . BARDI; K. BAUST; C. BERGER; E. CASTAGNOLA; K. A. DEVINE; J . GEBAUER; J. G. MARCHAK; A. W. GLASER; A. H. GROLL; G. M. HAEUSLER; J. DEN HARTOGH; R. HAUPT; L. HJORTH; M. KATO; Tomáš KEPÁK; M. M. W. KOOPMAN; T. LANGER; M. MAEDA; G. MICHEL; M. MURACA; P. C. NATHAN; S. R. VAN DEN OEVER; V. PAVASOVIC; S. SATO; F. SCHULTE; L. L. SUNG; W. TISSING; A. UYTTEBROECK; R. L. MULDER; C. KUEHNI; R. SKINNER; M. M. HUDSON a L. C. M. KREMER. Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group. \textit{PEDIATRIC BLOOD \&{}amp; CANCER}. HOBOKEN: WILEY, 2020, roč.~67, č.~12, s.~1-10. ISSN~1545-5009. Dostupné z: https://doi.org/10.1002/pbc.28702.

Přehled o publikaci